Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement
One out of 7 patients undergoing TAVR experienced periprocedural myocardial injury. VARC-3 periprocedural myocardial injury was associated with a 2-fold increased risk of cardiovascular death at 1 year after TAVR. The favorable association of RAS inhibitor prescription was consistent in patients with and without periprocedural myocardial injury. (SwissTAVI Registry; NCT01368250).
Authors
- David Reineke (ORCID: https://orcid.org/0000-0002-3317-6219)
- Daijiro Tomii (ORCID: https://orcid.org/0000-0002-4488-1335)
- Daryoush Samim (ORCID: https://orcid.org/0000-0002-0698-4456)
- Thomas Pilgrim (ORCID: https://orcid.org/0000-0001-8721-4068)
- Masaaki Nakase (ORCID: https://orcid.org/0000-0002-5359-8494)
- Jonas Lanz (ORCID: https://orcid.org/0000-0002-5035-6625)
- Stephan Windecker (ORCID: https://orcid.org/0000-0003-2653-6762)
- Stefan Stortecky (ORCID: https://orcid.org/0000-0002-5076-0177)
- Dik Heg
Institutions
- University of Bern (CH)
- University Hospital of Bern (CH)
Publication Details
- Journal
- JACC Advances
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1016/j.jacadv.2024.101212
- Citations
- 3
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.21